A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John E. Janik, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vall D'Hebron Institute of Oncology (vhio)
Barcelona, Spain
- University Hospital of Laussane (chuv)
Lausanne, Switzerland
- University College Hospital
London, United Kingdom
- University of Oxford
Oxford, United Kingdom
- Rutgers, the State University of New Jersey
New Brunswick, New Jersey, United States
- New York University Clinical Cancer Center
New York, New York, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2016
- Primary completion
- 26 Mar 2019
- Completion
- 26 Mar 2019
- Last update posted
- 24 Aug 2025
- Registered enrollment
- 87
- Registry id
- NCT02923349
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.